Genprex, Inc. Gains 47.4%
Fri, Sep 05, 2025 at 07:37 PM
Genprex, Inc. (GNPX:NASDAQ) jumped higher at $0.23, representing a gain of 47.4%. On Fri, Sep 05, 2025, GNPX:NASDAQ touched a New 2-Week High of $0.23. The stock got featured on our News Catalysts scanner on Tue, Sep 02, 2025 at 11:54 AM in the 'MISCELLANEOUS' category. From Fri, Aug 22, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Tue, Mar 18, 2025 at $0.52 with a volume of 44M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- CNFinance Holdings Limited (CNF:NYSE), 94.17%
- Hour Loop, Inc. (HOUR:NASDAQ), 93.12%
- Peraso Inc. (PRSO:NASDAQ), 68.7%
- Nova LifeStyle, Inc. (NVFY:NASDAQ), 64.79%
- Gelteq Limited (GELS:NASDAQ), 62.5%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 57.97%
- Genprex, Inc. (GNPX:NASDAQ), 47.4%
- Twin Vee Powercats Co. (VEEE:NASDAQ), 46.39%
- Concorde International Group Ltd. (CIGL:NASDAQ), 45.7%
- Pinnacle Food Group Limited (PFAI:NASDAQ), 44.44%